BeOne Medicines Ltd.SSE: 688235

Announcement on Change of Senior Executive

Jul 19, 2024 · Issued by BeOne Medicines Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 19, 2024

On 6ix: 6ix.com/news/announcement-on-change-of-senior-executive

Announcement on Change of Senior Executive

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

BeOne Medicines Ltd. on 6ix

Earlier from BeOne Medicines

Announcement on Key Financial Data of 1st Quarter of 2024May 9, 2024
Notice on Convening 2024 Annual General MeetingApr 29, 2024
2023 Annual ReportApr 27, 2024
Announcement on Voluntary Disclosure of European Commission's Approval of Baize'an (Tislelizumab Injection) for First-line and Second-line Treatment of Three Non-small Cell Lung Cancer IndicationsApr 24, 2024
Announcement on Convening 2023 Annual Performance MeetingApr 20, 2024

Later from BeOne Medicines

Announcement on Key Financial Data for the First Half Year of 2024Aug 8, 2024
Announcement on Convening Semi-annual Performance Briefing 2024Aug 22, 2024
Semi-annual Report in 2024Aug 30, 2024
Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024Sep 21, 2024
Announcement on the Appointment of Independent Non-executive Directors and Members of Audit Committee of the Board of DirectorsSep 27, 2024

All BeOne Medicines news releases

Follow BeOne Medicines into a list and get an email when it puts out news.

Follow BeOne Medicines